Literature DB >> 17601524

Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis.

Ravinder D Reddy1, Matcheri S Keshavan, Jeffrey K Yao.   

Abstract

OBJECTIVES: To determine whether blunted serotonergic responsivity, indicated by decreased platelet dense granule secretion (DGS), occurs in neuroleptic-naïve patients with schizophrenia, as observed previously in chronic schizophrenia. DESIGN AND METHODS: Serotonin (5-HT)-amplified DGS was examined in 40 first-episode neuroleptic-naïve patients (24 with schizophrenia and 16 with mood disorders) and 24 healthy subjects.
RESULTS: Healthy controls showed robustly increased DGS. Schizophrenic patients showed very modest DGS increases; mood disorder patients showed intermediate response.
CONCLUSIONS: Blunted DGS appears to a characteristic of schizophrenia that is observed in the treatment-naïve condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601524      PMCID: PMC2064870          DOI: 10.1016/j.clinbiochem.2007.04.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

1.  Increased platelet aggregability in major depression?

Authors:  F Lederbogen; M Gilles; A Maras; B Hamann; M Colla; I Heuser; M Deuschle
Journal:  Psychiatry Res       Date:  2001-07-24       Impact factor: 3.222

Review 2.  Mechanisms of platelet activation and inhibition.

Authors:  B Ashby; J L Daniel; J B Smith
Journal:  Hematol Oncol Clin North Am       Date:  1990-02       Impact factor: 3.722

3.  Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.

Authors:  P A McBride; G M Anderson; M E Hertzig; J A Sweeney; J Kream; D J Cohen; J J Mann
Journal:  Arch Gen Psychiatry       Date:  1989-03

4.  Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia.

Authors:  J K Yao; D P van Kammen; H B Moss; D E Sokulski
Journal:  Psychiatry Res       Date:  1996-07-31       Impact factor: 3.222

5.  Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.

Authors:  Ravinder D Reddy; Matcheri S Keshavan; Jeffrey K Yao
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

Review 6.  The role of serotonin in schizophrenia.

Authors:  A Bleich; S L Brown; R Kahn; H M van Praag
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

7.  Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.

Authors:  S Maayani; T Schwarz; B Craddock-Royal; T M Tagliente
Journal:  Platelets       Date:  2001-09       Impact factor: 3.862

8.  Platelet aggregation and dense granule secretion in schizophrenia.

Authors:  J K Yao; D P van Kammen; J Gurklis; J L Peters
Journal:  Psychiatry Res       Date:  1994-10       Impact factor: 3.222

9.  Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia.

Authors:  Jeffrey K Yao; Sharon Magan; Ali F Sonel; John A Gurklis; Richard Sanders; Ravinder D Reddy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-09       Impact factor: 4.006

10.  Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity.

Authors:  J K Yao; D P van Kammen
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

  10 in total
  1 in total

1.  Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.

Authors:  Hendrik Wesseling; Michael G Gottschalk; Sabine Bahn
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.